Literature DB >> 8084589

Ras- and Raf-dependent activation of c-jun transcriptional activity by the hepatitis B virus transactivator pX.

G Natoli1, M L Avantaggiati, P Chirillo, P L Puri, A Ianni, C Balsano, M Levrero.   

Abstract

The mechanisms by which pX, the transactivator of the Hepatitis B Virus (HBV), exerts its effects on transcription of viral and cellular genes have not yet been fully clarified. While previous reports suggested the possibility of a direct interaction of pX, which lacks intrinsic DNA-binding activity, with components of the cellular transcription machinery, more recent investigations support the hypothesis that pX might activate cellular kinases involved in transcriptional regulation and growth control. We analysed the mechanisms of c-Jun transcription factor activation by pX and in particular the role of cellular proteins involved in the transduction of mitogenic signals (namely Ha-Ras and Raf-1). In both HeLa and undifferentiated F9 cells pX was able to increase the activity of exogenous transfected c-Jun but not of c-Jun proteins bearing mutations in the serine residues located in the amino-terminal transcriptional activation domain. We show by use of Ha-Ras and Raf-1 dominant negative mutants that both Ha-Ras and Raf-1 are required for pX-induced activation of c-Jun transcriptional activity. In addition we show that pX is able to cooperate with Raf-1 in c-Jun activation. Our results are consistent with the hypothesis that at least one site of action of pX is peripheral and is located upstream of the Ras genes products.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8084589

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions.

Authors:  C R Madden; M J Finegold; B L Slagle
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

3.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 4.  The enigmatic X gene of hepatitis B virus.

Authors:  Michael J Bouchard; Robert J Schneider
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.

Authors:  N P Klein; R J Schneider
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.

Authors:  I Haviv; Y Matza; Y Shaul
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

7.  A composite polyadenylation signal with TATA box function.

Authors:  N Paran; A Ori; I Haviv; Y Shaul
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

8.  Cytochrome C oxidase III interacts with hepatitis B virus X protein in vivo by yeast two-hybrid system.

Authors:  Dan Li; Xiao-Zhong Wang; Jie-Ping Yu; Zhi-Xin Chen; Yue-Hong Huang; Qi-Min Tao
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

9.  A pre-S gene chip to detect pre-S deletions in hepatitis B virus large surface antigen as a predictive marker for hepatoma risk in chronic hepatitis B virus carriers.

Authors:  Fan-Ching Shen; Ih-Jen Su; Han-Chieh Wu; Yi-Hsuan Hsieh; Wei-Jen Yao; Kung-Chia Young; Tsung-Chuan Chang; Hui-Chuan Hsieh; Han-Ni Tsai; Wenya Huang
Journal:  J Biomed Sci       Date:  2009-09-15       Impact factor: 8.410

10.  The hepatitis B virus X protein activates nuclear factor of activated T cells (NF-AT) by a cyclosporin A-sensitive pathway.

Authors:  E Lara-Pezzi; A L Armesilla; P L Majano; J M Redondo; M López-Cabrera
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.